US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2071-4 D-0012-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2071-3 D-0011-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0010-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0009-2024
Class II · Moderate risk Terminated

rocuronium

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0008-2024
Class II · Moderate risk Terminated

PHENYLephrine in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6009-1 D-0007-2024
Class II · Moderate risk Terminated

PHENYLephrine in 0.9 sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6008-1 D-0006-2024
Class II · Moderate risk Terminated

lidocaine 2%

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0004-2024
Class II · Moderate risk Terminated

ePHEDrine in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6004-1 D-0003-2024
Class II · Moderate risk Terminated

ketamine in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-3022-1 D-0002-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2071-7 D-0001-2024
Class II · Moderate risk Terminated

Pantoprazole Sodium for Injection 40mg per vial

Reason Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.

Be Pharmaceuticals Ag NDC 71839-122-01 D-1148-2023
Class II · Moderate risk Ongoing

octiq Lubricating Eye Drops

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1167-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1166-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1165-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1164-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1163-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1162-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1161-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1159-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1158-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1157-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1156-2023